Catheter Precision Earnings Date & Estimates

Catheter Precision (NYSEAMERICAN:VTAK) is a medical device company focused on developing technologies for cardiac electrophysiology, a field involving the diagnosis and treatment of heart-rhythm disorders. Its products are designed to support physicians during procedures used to evaluate and treat cardiac arrhythmias, including ventricular tachycardia and other irregular heart rhythms.

The company’s product portfolio includes the VIVO system, a noninvasive 3D cardiac mapping and navigation platform intended to help clinicians identify the origin of ventricular arrhythmias and plan catheter-ablation procedures. Catheter Precision also markets LockeT, a device designed to help secure and manage catheters during electrophysiology procedures and support post-procedure access-site management.

Catheter Precision was formerly known as Ra Medical Systems and adopted its current name as it shifted its focus toward cardiac electrophysiology technologies. The company serves hospitals, cardiac centers and electrophysiology specialists, primarily in the United States and selected international markets where its products have received applicable regulatory clearances or approvals.